Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A High-Throughput Toxicity Screen of 42 Per- and Polyfluoroalkyl Substances (PFAS) and Functional Assessment of Migration and Gene Expression in Human Placental Trophoblast Cells. | Front Toxicol | 2022 | 35548680 | PubTator, text mining | PubMed |
| Susceptibility of Genetic Variations in Methylation Pathway to Gastric Cancer. | Pharmgenomics Pers Med | 2022 | 35548064 | PubTator, text mining | PubMed |
| Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression. | Front Oncol | 2022 | 35547880 | PubTator, text mining | PubMed |
| Exploring the Mechanism of Weikang Keli in Inhibiting Gastric Cancer through the MAPK Signaling Pathway: Based on Network Pharmacology and Experimental Verification. | Evid Based Complement Alternat Med | 2022 | 35547655 | PubTator, text mining | PubMed |
| Orphan receptors in prostate cancer. | Prostate | 2022 | 35538397 | PubTator, text mining | PubMed |
| Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. | Stem Cell Res Ther | 2022 | 35526071 | PubTator, text mining | PubMed |
| PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress. | Commun Biol | 2022 | 35508713 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer. | Oxid Med Cell Longev | 2022 | 35498135 | PubTator, text mining | PubMed |
| Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism. | Gastroenterology | 2022 | 35461826 | PubTator, text mining | PubMed |
| Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | Int J Mol Sci | 2022 | 35457118 | PubTator, text mining | PubMed |
| Therapeutic Strategies and Potential Actions of Female Sex Steroid Hormones and Their Receptors in Colon Cancer Based on Preclinical Studies. | Life (Basel) | 2022 | 35455096 | PubTator, text mining | PubMed |
| Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer. | Biomedicines | 2022 | 35453496 | PubTator, text mining | PubMed |
| Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients. | Hum Reprod | 2022 | 35451015 | PubTator, text mining | PubMed |
| Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation. | BMC Gastroenterol | 2022 | 35448958 | PubTator, text mining | PubMed |
| Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis. | Nat Commun | 2022 | 35440636 | PubTator, text mining | PubMed |
| Abnormal lipid synthesis as a therapeutic target for cancer stem cells. | World J Stem Cells | 2022 | 35432735 | PubTator, text mining | PubMed |
| A New Method on Construction of Brain Effective Connectivity Based on Functional Magnetic Resonance Imaging. | Comput Math Methods Med | 2022 | 35419076 | PubTator, text mining | PubMed |
| The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation. | Nat Commun | 2022 | 35418170 | PubTator, text mining | PubMed |
| The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy. | Biomol Ther (Seoul) | 2022 | 35410981 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=34